Efficacy subcutaneous ACTH Gel on Proteinuria, Progression of CKD

This trial of ACTH gel in 14 patients with ACE inhibitor-resistant nephrotic syndrome secondary to advanced diabetic nephropathy showed that 6 months of therapy significantly reduces proteinuria and stabilizes renal function in over half the patients (Journal of Diabetes Research)